Thyroid Cancer in Solid-Organ Transplant Recipients.

Area of Science:

• Oncology
• Transplant Surgery
• Endocrinology

Background:

• Solid-organ transplantation is a vital treatment for end-stage organ failure.
• Postoperative care significantly impacts transplant recipient outcomes.
• The association between solid-organ transplant and increased thyroid cancer risk remains debated.

Purpose of the Study:

• To investigate the incidence of thyroid cancer in solid-organ transplant recipients.
• To analyze the characteristics and outcomes of thyroid cancer in this patient population.

Main Methods:

• A retrospective cross-sectional study was conducted at a single center.
• Included 23 patients diagnosed with thyroid cancer post-liver or kidney transplant.
• Examined thyroid cancer types, postoperative thyroglobulin levels, and radioactive iodine therapy use.

Main Results:

• Thyroid malignancy was detected in 1.93% of 1191 solid-organ transplants (851 kidney, 340 liver).
• Papillary carcinoma was the predominant type (91.30%), with no cases directly attributed to transplant.
• Four patients died, with causes unrelated to thyroid cancer.

Conclusions:

• The incidence of thyroid cancer appears elevated in solid-organ transplant recipients.
• Mortality rates from thyroid cancer were not significantly affected in this cohort.
• Further research is warranted to understand the mechanisms and long-term implications.